Colon Cancer Clinical Trial

Comparing the ADR With Air Insufflation, Water Immersion and Water Exchange During Two-endoscopist Colonoscopy

Summary

Interval (missed) cancers and lower than expected mortality reduction of proximal colon cancers in the United States and elsewhere after screening colonoscopy drew attention to quality indicators. Missed adenomas which are more likely to be in the proximal colon may be contributing factors. An independent predictor of the risk of interval cancers is adenoma detection rate. In pilot observations, the investigators showed that water exchange enhanced adenoma detection in the right colon (cecum to hepatic flexure). This prospective, randomized controlled trial will compare water exchange with water immersion and traditional air insufflation in patients undergoing colonoscopy. The investigators test the hypothesis that compared with air insufflation and water immersion, water exchange produces a significantly higher adenoma detection rate in the right colon

View Full Description

Full Description

All of the procedures will be recorded and stored as digital files.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients undergoing colonoscopy performed by the participating endoscopists

Exclusion Criteria:

obstructive lesions of the colon known before colonoscopy
massive ascites
past history of partial colectomy
refusal to provide written informed consent

Study is for people with:

Colon Cancer

Estimated Enrollment:

371

Study ID:

NCT02737514

Recruitment Status:

Completed

Sponsor:

Dalin Tzu Chi General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Sepulveda Ambulatory Care Center, Veterans Affairs Greater
North Hills California, , United States
Dalin Tzu Chi General Hospital
Chia-Yi , 622, Taiwan

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

371

Study ID:

NCT02737514

Recruitment Status:

Completed

Sponsor:


Dalin Tzu Chi General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider